CoChat

Considerations for successful cancer immunotherapy in aged hosts

Open access
Hurez, Vincent, Padrón, Álvaro, Svatek, Robert S., Curiel, Tyler J. · 2018 · Experimental Gerontology
Cited by 46

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Improvements in understanding cancer immunopathogenesis have now led to unprecedented successes in immunotherapy to treat numerous cancers. Although aging is the most important risk factor for cancer, most pre‐clinical cancer immunotherapy studies are undertaken in young hosts. This review covers age‐related immune changes as they affect cancer immune surveillance, immunopathogenesis and immune therapy responses. Declining T cell function with age can impede efficacy of age‐related cancer immunotherapies, but examples of successful approaches to breach this barrier have been reported. It is further recognized now that immune functions with age do not simply decline, but that they change in potentially detrimental ways. For example, detrimental immune cell populations can become predominant during aging (notably pro‐inflammatory cells), the prevalence or function of suppressive cells can increase (notably myeloid derived suppressor cells), drugs can have age‐specific effects on immune cells, and attributes of the aged microenvironment can impede or subvert immunity. Key advances in these and related areas will be reviewed as they pertain to cancer immunotherapy in the aged, and areas requiring additional study and some speculations on future research directions will be addressed. We prefer the term Age Related Immune Dysfunction (ARID) as most encompassing the totality of age‐associated immune changes. HIGHLIGHTSThis article reviews major findings in age effects on immunity and how that affects cancer immunotherapy efficacy.Differences and similarities between mouse models and human data are discussed.This background is used to summarize key findings in efforts to use cancer immunotherapy successfully and optimally in aged patients.Major reviews are addressed and original source data are discussed.Areas for further investigations and testing are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.exger.2017.10.002

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 22 references

Cited by

See all 46

Metadata

Authors
Hurez, V., Padrón, Á., Svatek, R. S., & Curiel, T. J.
Venue
Experimental Gerontology
Publisher
Elsevier BV
Published
2018-07
Volume
107
Pages
27-36
ISSN
0531-5565 (ISSN-L)
OpenAlex
W2763883091
Cited by
46
References
22
FWCI
2.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Considerations for successful cancer immunotherapy in aged hosts. https://app.cochat.ai/papers/10.1016/j.exger.2017.10.002
The paper
Hurez, V., Padrón, Á., Svatek, R. S., & Curiel, T. J. (2018). Considerations for successful cancer immunotherapy in aged hosts. Experimental Gerontology. https://doi.org/10.1016/j.exger.2017.10.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.